Important insights for non-molar choriocarcinoma

BJOG. 2020 Aug;127(9):1108. doi: 10.1111/1471-0528.16235. Epub 2020 Apr 17.

Authors

N S Horowitz^{1

2

3}, R S Berkowitz^{1

2

3}, K M Elias^{1

2

3}

Affiliations

¹ New England Trophoblastic Disease Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 32232902
DOI: 10.1111/1471-0528.16235

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Choriocarcinoma*
Demography
Female
Humans
Hydatidiform Mole*
Pregnancy
Treatment Outcome
United Kingdom

Grants and funding

Donald P. Goldstein MD Trophoblastic Tumor Registry Endowment and the Dyett Family Trophoblastic Disease Research and Registry Endowment/International